Trial intelligence / Profile preview

Phase 3 trial of Prevenar 13 versus Prevenar in healthy infants in Brazil

2008-004768-38Phase 3

Sponsor
Wyeth
Start
Apr 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pneumococcal 13-valent conjugate vaccine and pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 arms), sponsored by Wyeth.

02

Drugs

pneumococcal 13-valent conjugate vaccinepneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on 2008-004768-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004768-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call